Articles by Daniel Marsh
Immunovant Shares Surge on Promising Arthritis Drug Data
Immunovant shares soared 35% after its experimental rheumatoid arthritis drug, IMVT-1402, demonstrated high response rates in a difficult-to-treat patient population, prompting a re-rating by Wall Street.
FuelCell Energy Stock Jumps 16.5% on Renewed AI Data Center Optimism, Analysts Remain Cautious
FuelCell Energy shares surged 16.5% to $20.22 on renewed AI data center demand, but analysts remain cautious as the company reported a $26.1M loss and declining backlog.
RBC Shares Hit Fresh 52-Week High Ahead of Q2 Earnings Report
RBC shares hit a 52-week high of C$257.91 on Wednesday, rising 1.99% to C$257.55, ahead of its Q2 earnings release on May 28.
HCW Biologics Rockets 122% as Traders Flock to Micro-Cap Biotech
HCW Biologics shares skyrocketed 122% to $2.35 on Wednesday as traders piled into the micro-cap biotech, fueled by a new stock offering and first-quarter revenue of $6.54 million from a licensing deal.
Bradesco Stock Climbs 3.28% as Brazil Bank Rally Faces Key Credit Test
Banco Bradesco preferred shares rose 3.28% to R$17.96 on Wednesday, outperforming the Ibovespa, as Q1 net income climbed 16.1% but loan-loss provisions jumped 26.5%. The bank's rally faces a test from rising delinquencies and high interest rates.
Norwegian Cruise Line Surges 9% as Oil Plunge Eases Fuel Cost Pressure
Norwegian Cruise Line Holdings shares rose 9.2% as oil prices fell nearly 6%, easing fuel cost concerns. Insider buying and a bounce from a four-day slide boosted sentiment.
AT&T Stock Dips on Fiber Expansion and Cash Return Concerns
AT&T shares slipped 0.3% as investors weigh fiber growth, $45B shareholder return plan, and satellite strategy. CEO Stankey reaffirmed Q2 cash flow guidance.
Ford Gains on Energy Storage Partnership with EDF
Ford shares gained 1.8% as its energy storage unit signed a five-year agreement with EDF for up to 20 GWh of battery systems. The automaker reported solid Q1 results and provided an optimistic full-year outlook.
Rivian R2 Production Ramp Drives Stock Rebound
Rivian stock climbed 4.4% to $13.465 after a production update on the R2 SUV. The company targets 155,000 units annually at its Illinois plant.